Dec 7, 2022

Featuring perspectives from Prof Karim Fizazi and Prof Stéphane Oudard, including the following topics:

• Introduction: Journal Club — Karim Fizazi, MD, PhD and Stéphane Oudard, MD, PhD (0:00)
• Case: A man in his late 50s with Gleason 7 prostate cancer after prostatectomy/radiation therapy/androgen deprivation...

Nov 9, 2022

Featuring perspectives from Dr Matthew Smith, including the following topics:

• Introduction: Abemaciclib for Prostate Cancer? (0:00)
• Case: A man in his early 70s with a PSA of 150 ng/mL, Gleason 4 + 4 and upper abdominal adenopathy — Jennifer L Dallas, MD (9:30)
• Case: A man in his late 60s with Gleason 4 + 4, PSA of...

Jul 14, 2022

PARP Inhibition in the Management of Prostate Cancer — Where We Are and Where We’re Headed — Faculty Presentation 2: Available Data with, Ongoing Investigation of and Potential Future Role of PARP Inhibitor-Based Combination Strategies — Dr Fred Saad

CME information and select...

Jul 14, 2022

PARP Inhibition in the Management of Prostate Cancer — Where We Are and Where We’re Headed — Faculty Presentation 1: Optimal Integration of PARP Inhibitor Monotherapy into the Management of Metastatic Castration-Resistant Prostate Cancer — Prof Johann de Bono

CME information and select...

Jul 14, 2022